Nisa Leung is a Partner of Qiming Ventures specializing in health care investments. Prior to joining Qiming, she was co-founder of Biomedic Holdings with operations and investments in medical devices, pharmaceuticals and health care services in China including most recently a founding investment into Novamed Pharmaceuticals Inc (Shanghai), a specialty pharmaceutical company focused on oncology and CNS. Nisa was Venture Partner of PacRim Ventures in Menlo Park, and was previously with Softbank/Mobius Venture Capital.

Nisa currently sits on the board of Biomedic Holdings (Shanghai) and related companies, Cardiva Medical (Mountain View CA), American Cancer Centers (Shanghai), Crown Biosciences and Novast Pharmaceuticals. Nisa also represented Qiming on investments in Alltech, Gammastar and Guokang.

Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is member of Cornell University Council and the only non-US member of Cornell Life Sciences Advisory Board.